Compounded vial vs brand pen - what's actually different?
Brand pens (Wegovy, Ozempic, Mounjaro, Zepbound) are pre-filled, fixed-dose, factory-tested, and sold through a pharmacy with a prescription. Compounded vials come from a licensed compounding pharmacy in a glass vial with bac water and an insulin syringe, are usually cheaper, and let you draw the dose your provider prescribes with an insulin syringe - including in-between amounts a fixed-dose pen cannot. Compounders sometimes add B12 or other ingredients. The active ingredient is the same; the legal status, oversight, and dose flexibility are different.
- Brand-name semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are made by Novo Nordisk and Lilly as FDA-approved products under sterile manufacturing standards
- Licensed 503A pharmacies and 503B outsourcing facilities may compound semaglutide or tirzepatide only under specific legal conditions, such as a documented drug shortage or a clinical need the FDA-approved product cannot meet; FDA's shortage-based allowances have narrowed as brand supply stabilized
- Brand pens deliver a fixed dose per click; compounded vials require drawing the dose your prescription specifies with a U-100 insulin syringe
- Some compounded formulations include added ingredients such as cyanocobalamin (B12) or pyridoxine (B6); these add-ins are pharmacy formulation choices and are not part of the FDA-approved product
- A compound from a licensed pharmacy is legally distinct from an unapproved 'research' peptide bought from a non-pharmacy site
Your guided peptide companion.
PRTCL walks beginners through their first peptide with confidence - guided reconstitution, syringe unit math from your own numbers, vial tracking, and answers to questions like this one. Built for first-timers, useful for everyone.
- · Guided walkthrough for your first dose
- · Your vial and your dose, converted into syringe units
- · Vial inventory and dose log tracking
- · A library where every claim cites its source
Free to start.